Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors

Infection

Volumn 40, Issue 1, 2012, Pages 19-26

  Chiang, M C ^a   Kuo, S C ^a,c   Chen, S J ^a   Yang, S P ^a   Lee, Y T ^b,c   Chen, T L ^a,c   Fung, C P ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Chutung Veterans Hospital   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter baumannii complex (ABC); Bacteremia; Genomic species; Outcome; Solid tumor

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLADDER CANCER; BRAIN TUMOR; BREAST CANCER; CLINICAL FEATURE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FEMALE; HAZARD RATIO; HEAD AND NECK CANCER; HEALTH CARE FACILITY; HUMAN; INTENSIVE CARE UNIT; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTATE CANCER; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SPECIES DIFFERENCE; STOMACH CANCER;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; AGED, 80 AND OVER; BACTEREMIA; DNA, BACTERIAL; DNA, RIBOSOMAL SPACER; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; MULTIVARIATE ANALYSIS; NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84857782309     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0187-4     Document Type: Article

References (43)

1. JY Jung MS Park SE Kim BH Park JY Son EY Kim JE Lim SK Lee SH Lee KJ Lee YA Kang SK Kim J Chang YS Kim 2010 Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit BMC Infect Dis 10 228 20670453 10.1186/1471-2334-10-228
2. E Velasco R Byington CS Martins M Schirmer LC Dias VM Gonçalves 2004 Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects Clin Microbiol Infect 10 542 549 15191383 10.1111/j.1469-0691.2004.00874.x 1:STN:280:DC%2BD2c3ptFCrsQ%3D%3D (Pubitemid 38961580)
3. JY Fagon J Chastre Y Domart JL Trouillet C Gibert 1996 Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush Clin Infect Dis 23 538 542 8879777 10.1093/clinids/23.3.538 1:STN:280:DyaK2s%2FjsVWhsw%3D%3D (Pubitemid 26304504)
4. CM Beck-Sagué WR Jarvis JH Brook DH Culver A Potts E Gay BW Shotts B Hill RL Anderson MP Weinstein 1990 Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units Am J Epidemiol 132 723 733 2403113 (Pubitemid 20344540)
5. D Villers E Espaze M Coste-Burel F Giauffret E Ninin F Nicolas H Richet 1998 Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology Ann Intern Med 129 182 189 9696725 1:STN:280:DyaK1czkvVaqsw%3D%3D (Pubitemid 28377507)
6. HP Chen TL Chen CH Lai CP Fung WW Wong KW Yu CY Liu 2005 Predictors of mortality in Acinetobacter baumannii bacteremia J Microbiol Immunol Infect 38 127 136 15843858
7. O Lortholary JY Fagon AB Hoi MA Slama J Pierre P Giral R Rosenzweig L Gutmann M Safar J Acar 1995 Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis Clin Infect Dis 20 790 796 7795075 10.1093/clinids/20.4.790 1:STN:280:DyaK2MzhsFektQ%3D%3D
8. KJ Towner 2009 Acinetobacter: an old friend, but a new enemy J Hosp Infect 73 355 363 19700220 10.1016/j.jhin.2009.03.032 1:STN:280: DC%2BD1MjmsFOjuw%3D%3D
9. NY Lee TC Chang CJ Wu CM Chang HC Lee PL Chen CC Lee NY Ko WC Ko 2010 Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia J Infect 61 219 227 20624424 10.1016/j.jinf.2010.07.002
10. L Dijkshoorn A Nemec H Seifert 2007 An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat Rev Microbiol 5 939 951 18007677 10.1038/nrmicro1789 1:CAS:528:DC%2BD2sXhtlajtL7L (Pubitemid 350131182)
11. AY Peleg H Seifert DL Paterson 2008 Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 538 582 18625687 10.1128/CMR.00058-07 1:CAS:528:DC%2BD1cXpslajs7Y%3D
12. YT Lee LY Huang DH Chiang CP Chen TL Chen FD Wang CP Fung LK Siu WL Cho 2009 Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan Int J Antimicrob Agents 34 580 584 19733035 10.1016/j.ijantimicag.2009.06.027 1:CAS:528:DC%2BD1MXhtlGhs7jF
13. ML Joly-Guillou 2005 Clinical impact and pathogenicity of Acinetobacter Clin Microbiol Infect 11 868 873 16216100 10.1111/j.1469-0691.2005.01227.x (Pubitemid 41535922)
14. YM Lim KS Shin J Kim 2007 Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates J Clin Microbiol 45 902 905 17192417 10.1128/JCM.01573-06 1:CAS:528:DC%2BD2sXktFOgt78%3D (Pubitemid 46427709)
15. YC Lin WH Sheng YC Chen SC Chang KC Hsia SY Li 2010 Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan Int J Antimicrob Agents 35 439 443 20106635 10.1016/j.ijantimicag.2009.11.020 1:CAS:528:DC%2BC3cXjs12gt7o%3D
16. JH Lee CH Choi HY Kang JY Lee J Kim YC Lee SY Seol DT Cho KW Kim Y Song do JC Lee 2007 Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU J Antimicrob Chemother 59 633 639 17339277 10.1093/jac/dkm007 1:CAS:528:DC%2BD2sXltVKhu70%3D (Pubitemid 47073395)
17. ET Houang YW Chu KY Chu KC Ng CM Leung AF Cheng 2003 Significance of genomic DNA group delineation in comparative studies of antimicrobial susceptibility of Acinetobacter spp. Antimicrob Agents Chemother 47 1472 1475 12654697 10.1128/AAC.47.4.1472-1475.2003 1:CAS:528:DC%2BD3sXivVSmsb0%3D (Pubitemid 36368624)
18. PJ van den Broek J Arends AT Bernards E De Brauwer EM Mascini TJ van der Reijden L Spanjaard EA Thewessen A van der Zee JH van Zeijl L Dijkshoorn 2006 Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001 Clin Microbiol Infect 12 837 843 16882288 10.1111/j.1469-0691. 2006.01510.x (Pubitemid 44151283)
19. H Wisplinghoff MB Edmond MA Pfaller RN Jones RP Wenzel H Seifert 2000 Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility Clin Infect Dis 31 690 697 11017817 10.1086/314040 1:CAS:528:DC%2BD3cXotV2gsbY%3D (Pubitemid 32295488)
20. TL Chen LK Siu RC Wu MF Shaio LY Huang CP Fung CM Lee WL Cho 2007 Comparison of one-tube multiplex PCR, automated ribotyping and intergenic spacer (ITS) sequencing for rapid identification of Acinetobacter baumannii Clin Microbiol Infect 13 801 806 17488329 10.1111/j.1469-0691.2007.01744.x 1:CAS:528:DC%2BD2sXpslOlt7w%3D (Pubitemid 47039914)
21. HC Chang YF Wei L Dijkshoorn M Vaneechoutte CT Tang TC Chang 2005 Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region J Clin Microbiol 43 1632 1639 15814977 10.1128/JCM.43.4.1632-1639.2005 1:CAS:528:DC%2BD2MXjvF2ltLs%3D
22. LY Huang TL Chen PL Lu CA Tsai WL Cho FY Chang CP Fung LK Siu 2008 Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan Clin Microbiol Infect 14 1010 1019 19040472 10.1111/j.1469-0691.2008.02077.x 1:CAS:528:DC%2BD1MXhtVWksLg%3D (Pubitemid 352748841)
23. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: M100-S20. Wayne, PA: CLSI;2010.
24. DH Chiang CC Wang HY Kuo HP Chen TL Chen FD Wang WL Cho CY Liu 2008 Risk factors for mortality in patients with Acinetobacter baumannii bloodstream infection with genotypic species identification J Microbiol Immunol Infect 41 397 402 19122921 1:CAS:528:DC%2BD1MXltlymsrg%3D
25. DL Paterson 2006 The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species Clin Infect Dis 43 S43 S48 16894514 10.1086/504476 (Pubitemid 44267139)
26. E Gkrania-Klotsas RC Hershow 2006 Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality Clin Infect Dis 43 1224 1225 17029151 10.1086/508360 (Pubitemid 44632815)
27. JL García-Garmendía C Ortiz-Leyba J Garnacho-Montero FJ Jiménez-Jiménez J Monterrubio-Villar M Gili-Miner 1999 Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients Crit Care Med 27 1794 1799 10507600 10.1097/00003246-199909000-00015 (Pubitemid 29455106)
28. JM Cisneros MJ Reyes J Pachón B Becerril FJ Caballero JL García-Garmendía C Ortiz AR Cobacho 1996 Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features Clin Infect Dis 22 1026 1032 8783704 10.1093/clinids/22.6.1026 1:STN:280:DyaK28znsl2huw%3D%3D (Pubitemid 26260606)
29. S Blot K Vandewoude F Colardyn 2003 Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study Intensive Care Med 29 471 475 12577148 (Pubitemid 36379452)
30. J Garnacho J Sole-Violan M Sa-Borges E Diaz J Rello 2003 Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study Crit Care Med 31 2478 2482 14530754 10.1097/01.CCM.0000089936. 09573.F3 (Pubitemid 37281732)
31. MC Albrecht ME Griffith CK Murray KK Chung EE Horvath JA Ward DR Hospenthal JB Holcomb SE Wolf 2006 Impact of Acinetobacter infection on the mortality of burn patients J Am Coll Surg 203 546 550 17000400 10.1016/j.jamcollsurg.2006.06.013 (Pubitemid 44416250)
32. ME Falagas P Kopterides II Siempos 2006 Attributable mortality of Acinetobacter baumannii infection among critically ill patients Clin Infect Dis 43 389 16804863 10.1086/505599 author reply 389-90 (Pubitemid 44078919)
33. E Bergogne-Bérézin KJ Towner 1996 Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features Clin Microbiol Rev 9 148 165 8964033 (Pubitemid 26123943)
34. LS Munoz-Price RA Weinstein 2008 Acinetobacter infection N Engl J Med 358 1271 1281 18354105 10.1056/NEJMra070741 1:CAS:528:DC%2BD1cXjvVWmtLg%3D (Pubitemid 351439228)
35. TW Boo F Walsh B Crowley 2009 Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3 J Med Microbiol 58 209 216 19141738 10.1099/jmm.0.004911-0 1:CAS:528:DC%2BD1MXivFSqt7Y%3D
36. Liang-Yu C, Kuo SC, Liu CY, Luo BS, Huang LJ, Lee YT, Chen CP, Chen TL, Fung CP. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007. J Microbiol Immunol Infect. 2011;Epub ahead of print.
37. A Erbay A Idil MG Gözel I Mumcuoǧlu N Balaban 2009 Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections Int J Antimicrob Agents 34 575 579 19740628 10.1016/j.ijantimicag.2009.07.006 1:CAS:528:DC%2BD1MXhtlGhs7jE
38. CH Chen LC Lin YJ Chang CC Huang CE Liu TG Young 2003 Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia Infection 31 331 335 14556059
39. NC Gordon DW Wareham 2010 Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance Int J Antimicrob Agents 35 219 226 20047818 10.1016/j.ijantimicag.2009.10.024 1:CAS:528:DC%2BC3cXotVeiug%3D%3D
40. M Eveillard C Soltner M Kempf JP Saint-André C Lemarié C Randrianarivelo H Seifert M Wolff ML Joly-Guillou 2009 The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia J Infect 60 154 161 19748521 10.1016/j.jinf.2009.09.004
41. C Routsi M Pratikaki E Platsouka C Sotiropoulou S Nanas V Markaki C Vrettou O Paniara H Giamarellou C Roussos 2010 Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes Infection 38 173 180 20224962 10.1007/s15010-010-0008-1 1:CAS:528:DC%2BC3cXmslOmsrc%3D
42. AF Martins R Kuchenbecker T Sukiennik R Boff KC Reiter L Lutz AB Machado AL Barth 2009 Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil Infection 37 474 476 19768380 10.1007/s15010-009-9003-9 1:STN:280:DC%2BC3c%2FntVKrsw%3D%3D
43. M Wadl K Heckenbach I Noll S Ziesing W Pfister J Beer S Schubert T Eckmanns 2010 Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002-2006 Infection 38 47 51 20108161 10.1007/s15010-009-9225-x 1:CAS:528:DC%2BC3cXit1OlsLg%3D